An interim analysis of a randomized controlled trial testing an app-based cognitive training program in patients with mild dementia found that those who used the app alongside standard care scored better on the Montreal Cognitive Assessment (MoCA) after 12 weeks than patients who received standard care alone, according to results published in Alzheimer's & Dementia on December 23, 2025. In the dementia arm of the trial, 27 patients (average age 81, 13 women) were randomized; scores on the 30-point MoCA fell by 1.71 points in the standard-care group over 12 weeks while rising by 0.54 points in the group that also used the app, a difference the researchers reported as statistically significant (p = 0.038).

The trial, called MEMODIO_APP@CARE and registered with the German Clinical Trials Register (DRKS00033494), tests the memodio app, which combines cognitive exercises, physical activity prompts and psychoeducation on brain health, against standard of care in patients with mild cognitive impairment or mild dementia. The dementia results reported here are a preliminary look at one arm of that trial; a separate, earlier interim analysis of the trial's larger mild cognitive impairment arm (42 patients), published in European Psychiatry in August 2025, reported a similar pattern on MoCA scores in that group.

The researchers, from memodio GmbH and university hospitals in Cologne and Mannheim, Germany, reported that other measured outcomes in the dementia arm, including quality of life, physical activity and activities of daily living, did not reach statistical significance at this interim stage, though they described those measures as trending positive in the app group relative to baseline. The findings were presented as a conference abstract (an 'ePresentation') rather than as a full peer-reviewed manuscript, and the authors themselves labeled the results 'preliminary.'